Showing papers in "Diabetes & Metabolism in 2022"

TL;DR: In this paper , the authors investigated whether metabolic dysfunction-associated fatty liver disease (MAFLD) identifies a higher proportion of individuals at risk of developing chronic kidney disease (CKD).

TL;DR: In this article , the authors assess the impact of bariatric surgery on remission and relapse of type 2 diabetes mellitus (T2DM) at 10 years of follow-up and analyze predictive factors.

TL;DR: In this article , a joint position statement by the French-speaking Society on Tobacco (Société Francophone de Tabacologie) and the French speaking Society of Diabetes (Societé Francophonie du Diabète) summarizes the data available on the association between smoking and diabetes and on the impact of smoking and smoking cessation among individuals with type 1, type 2, and gestational diabetes mellitus.

TL;DR: In this paper , a meta-analysis of 12 retrospective cohorts revealed significant increase in LLA with a HR 1.15 (95% CI 1.05-1.24, I² 69%) when comparing SGLT2i users versus GLP-1RA users.

TL;DR: In this paper , the authors showed that there is no evidence of an increased risk of acute kidney injury with RAAS blocker-SGLT2i combinations in absence of haemodynamic instability, despite the fact that a majority of patients received RAAS blockers at baseline.

TL;DR: In this article , the authors investigated the prevalence of biopsy-proven non-alcoholic steatohepatitis (NASH) in a cohort of patients with morbid obesity and with or without type 2 diabetes (T2D) and to find non-invasive predictors of NASH severity.

TL;DR: In this article , Wu et al. examined whether there are any associations between serum uric acid (UA) in early pregnancy and the subsequent risk of gestational diabetes mellitus (GDM).

TL;DR: In this article , the effects of each pharmacological class on the risk of new-onset atrial fibrillation/flutter (AF/AFL) episodes in patients with type 2 diabetes mellitus (T2DM) and patients with heart failure (with or without diabetes).

TL;DR: In this article , dipeptidyl peptidase-4 inhibitors (DPP4i) were shown to reduce inflammation and prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) entry.

TL;DR: In this paper , the authors investigated the prevalence of GDM in a SARS-CoV-2 infected pregnant population and evaluated risk factors for and from severe infection in these patients.

TL;DR: Wang et al. as discussed by the authors investigated the associations of metabolic health and its transition with heart failure across body mass index (BMI) and waist circumference (WC) categories and concluded that maintaining metabolic health may provide a clue for preventing heart failure.

TL;DR: In this article , the authors evaluated the association between SGLT2 inhibitors and incident glaucoma, and found that those who were newly prescribed SGLTs had a lower risk of glaucka compared to those prescribed GLTs in clinical practice.

TL;DR: In this paper , the authors investigated the relationship between triglyceride-glucose (TyG) index and incident heart failure (HF) using restricted cubic spline analysis and Cox proportional hazard models.

TL;DR: In this paper , the diagnostic value of the triglycerides and glucose (TyG) index, an insulin-resistance indicator, was determined to predict NASH, NAFLD, and fibrosis.

TL;DR: In this article , the authors analyzed the association of objective and subjective sleep measures with HbA1c and insulin sensitivity in the general population in the ORISCAV-LUX-2 study.

TL;DR: In this paper , a Cox proportional hazards model was used to evaluate the relationship between sleep duration and all-cause mortality in adults with type 2 diabetes, and a J-shaped relationship was identified.

TL;DR: A comparison of the multifactorial pathophysiological mechanisms of Covid-19 progression with metformin's well-known pleiotropic properties suggests that the treatment of patients with this drug might be particularly beneficial as mentioned in this paper .

TL;DR: In this article , the authors performed a meta-analysis to summarize the most recent evidence on the renal benefits of GLP-1 receptor agonists from clinical trials of patients with type 2 diabetes.

TL;DR: In this article , the authors examined the predictive value of HbA1c at GDM diagnosis with adverse pregnancy outcomes and concluded that a single Hb1c reading may be a useful pragmatic tool to identify women at risk.

TL;DR: In this paper , the effects of glucose-lowering agents on the risk of ventricular arrhythmias and sudden cardiac arrest/death (SCA/SCD) remain poorly understood.

TL;DR: Wang et al. as mentioned in this paper investigated the association between metformin and bone mineral density (BMD) in a large cohort of Chinese patients with type 2 diabetes mellitus (T2DM).

TL;DR: Early life Bacillus Calmette-Guerin vaccination was associated with lower risks of both type 1 and type 2 diabetes from early to middle adulthood, but not of LADA as mentioned in this paper .

TL;DR: In this paper , the authors compared the risk of pneumonia and sepsis between SGLT2 inhibitors and dipeptidyl peptidase 4 (DPP-4) inhibitors in patients with type 2 diabetes.

TL;DR: In this article , a large-scale study of subjects with familial partial lipodystrophy type 2 (FPLD2) was conducted, and the results showed that 65% had either diabetes (41%) or prediabetes (24%) despite their young age (median: 39.5 years IQR 29.0-50.8) and close-to-normal BMI (medians: 25.5 kg/m2 IQR 23.1-29.4).

TL;DR: In this paper , a continuous association between large-forgestational-age (LGA) infants and seven increasing categories of fasting plasma glucose (PG), 1-hour and 2-hour PG values after a 75 g oral glucose tolerance test at 24-32 gestational weeks was found.

TL;DR: In this paper , the influence of dipeptidyl peptidase-4 inhibitors (DPP4i) versus sulfonylureas (SU) on major adverse cardiovascular events (MACEs), including acute myocardial infarction, cerebrovascular disease, heart failure, malignant dysrhythmia, and revascularisation, was evaluated.

TL;DR: In this paper , the pancreatic and gut hormone responses to a mixed meal test in post-chronic pancreatitis diabetes mellitus (PPDM-C) patients, compared with non-diabetic chronic pancreatitis (CP), and type 2 diabetes patients or healthy controls were investigated.